327 related articles for article (PubMed ID: 10966937)
21. Neuronal nitric oxide synthase-dependent afferent arteriolar function in angiotensin II-induced hypertension.
Ichihara A; Imig JD; Navar LG
Hypertension; 1999 Jan; 33(1 Pt 2):462-6. PubMed ID: 9931148
[TBL] [Abstract][Full Text] [Related]
22. Renoprotective effects of neuronal NOS-derived nitric oxide and cyclooxygenase-2 metabolites in transgenic rats with inducible malignant hypertension.
Patterson ME; Mullins JJ; Mitchell KD
Am J Physiol Renal Physiol; 2008 Jan; 294(1):F205-11. PubMed ID: 17977909
[TBL] [Abstract][Full Text] [Related]
23. Roles of nitric oxide and oxidative stress in the regulation of blood pressure and renal function in prehypertensive Ren-2 transgenic rats.
Vanecková I; Kramer HJ; Novotná J; Kazdová L; Opocenský M; Bader M; Ganten D; Cervenka L
Kidney Blood Press Res; 2005; 28(2):117-26. PubMed ID: 15795515
[TBL] [Abstract][Full Text] [Related]
24. Role of neuronal nitric oxide in the inhibition of sympathetic vasoconstriction in resting and contracting skeletal muscle of healthy rats.
Jendzjowsky NG; DeLorey DS
J Appl Physiol (1985); 2013 Jul; 115(1):97-106. PubMed ID: 23640592
[TBL] [Abstract][Full Text] [Related]
25. Glomerulosclerosis in the diet-induced obesity model correlates with sensitivity to nitric oxide inhibition but not glomerular hyperfiltration or hypertrophy.
Polichnowski AJ; Licea-Vargas H; Picken M; Long J; Bisla R; Williamson GA; Bidani AK; Griffin KA
Am J Physiol Renal Physiol; 2015 Nov; 309(9):F791-9. PubMed ID: 26109088
[TBL] [Abstract][Full Text] [Related]
26. Contribution of endothelial nitric oxide synthase in the blunted renal responses to volume expansion in diabetic rats.
Wongmekiat O; Johns E
Exp Physiol; 2001 Jul; 86(4):481-8. PubMed ID: 11445827
[TBL] [Abstract][Full Text] [Related]
27. An analysis of renal nitric oxide contribution to hyperfiltration in diabetic rats.
Schwartz D; Schwartz IF; Blantz RC
J Lab Clin Med; 2001 Feb; 137(2):107-14. PubMed ID: 11174467
[TBL] [Abstract][Full Text] [Related]
28. Chronic NOS inhibition reverses systemic vasodilation and glomerular hyperfiltration in pregnancy.
Cadnapaphornchai MA; Ohara M; Morris KG; Knotek M; Rogachev B; Ladtkow T; Carter EP; Schrier RW
Am J Physiol Renal Physiol; 2001 Apr; 280(4):F592-8. PubMed ID: 11249850
[TBL] [Abstract][Full Text] [Related]
29. Cellular transport of l-arginine determines renal medullary blood flow in control rats, but not in diabetic rats despite enhanced cellular uptake capacity.
Persson P; Fasching A; Teerlink T; Hansell P; Palm F
Am J Physiol Renal Physiol; 2017 Feb; 312(2):F278-F283. PubMed ID: 27927650
[TBL] [Abstract][Full Text] [Related]
30. Knockout of Na
Song P; Huang W; Onishi A; Patel R; Kim YC; van Ginkel C; Fu Y; Freeman B; Koepsell H; Thomson S; Liu R; Vallon V
Am J Physiol Renal Physiol; 2019 Jul; 317(1):F207-F217. PubMed ID: 31091127
[TBL] [Abstract][Full Text] [Related]
31. Role of nitric oxide in the early renal hemodynamic response after unilateral nephrectomy.
Valdivielso JM; Pérez-Barriocanal F; García-Estañ J; López-Novoa JM
Am J Physiol; 1999 Jun; 276(6):R1718-23. PubMed ID: 10362752
[TBL] [Abstract][Full Text] [Related]
32. Modulation of the myogenic response in renal blood flow autoregulation by NO depends on endothelial nitric oxide synthase (eNOS), but not neuronal or inducible NOS.
Dautzenberg M; Keilhoff G; Just A
J Physiol; 2011 Oct; 589(Pt 19):4731-44. PubMed ID: 21825026
[TBL] [Abstract][Full Text] [Related]
33. Nitric oxide may be required to prevent hypertension at the onset of diabetes.
Fitzgerald SM; Brands MW
Am J Physiol Endocrinol Metab; 2000 Oct; 279(4):E762-8. PubMed ID: 11001756
[TBL] [Abstract][Full Text] [Related]
34. Nitric oxide inhibition and the impact on renal nerve-mediated antinatriuresis and antidiuresis in the anaesthetized rat.
Bagnall NM; Dent PC; Walkowska A; Sadowski J; Johns EJ
J Physiol; 2005 Dec; 569(Pt 3):849-56. PubMed ID: 16239274
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of intrarenal NO stimulates renin secretion through a macula densa-mediated mechanism.
Schnackenberg CG; Tabor BL; Strong MH; Granger JP
Am J Physiol; 1997 Mar; 272(3 Pt 2):R879-86. PubMed ID: 9087651
[TBL] [Abstract][Full Text] [Related]
36. Renal sodium handling in experimental diabetes: role of NO.
Komers R; Cooper ME
Nephrol Dial Transplant; 1996 Nov; 11(11):2170-7. PubMed ID: 8941575
[TBL] [Abstract][Full Text] [Related]
37. Role of the macula densa sodium glucose cotransporter type 1-neuronal nitric oxide synthase-tubuloglomerular feedback pathway in diabetic hyperfiltration.
Zhang J; Cai J; Cui Y; Jiang S; Wei J; Kim YC; Chan J; Thalakola A; Le T; Xu L; Wang L; Jiang K; Wang X; Wang H; Cheng F; Buggs J; Koepsell H; Vallon V; Liu R
Kidney Int; 2022 Mar; 101(3):541-550. PubMed ID: 34843754
[TBL] [Abstract][Full Text] [Related]
38. Nitric oxide-angiotensin II interactions and renal hemodynamic function in patients with uncomplicated type 1 diabetes.
Montanari A; Pelà G; Musiari L; Crocamo A; Boeti L; Cabassi A; Biggi A; Cherney DZ
Am J Physiol Renal Physiol; 2013 Jul; 305(1):F42-51. PubMed ID: 23657857
[TBL] [Abstract][Full Text] [Related]
39. Cyclic GMP mediates influence of macula densa nitric oxide over tubuloglomerular feedback.
Thomson SC; Deng A
Kidney Blood Press Res; 2003; 26(1):10-8. PubMed ID: 12697972
[TBL] [Abstract][Full Text] [Related]
40. Effect of orchiectomy on renal function in control and diabetic rats with chronic inhibition of nitric oxide.
Anderson S; Chapman JG; Oyama TT; Komers R
Clin Exp Pharmacol Physiol; 2010 Jan; 37(1):19-23. PubMed ID: 19473197
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
